SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-22-000005
Filing Date
2022-01-11
Accepted
2022-01-11 16:46:47
Documents
13
Period of Report
2022-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20220105.htm   iXBRL 8-K 38318
2 EX-99.1 amendment3tonedcp.htm EX-99.1 8592
  Complete submission text file 0001410939-22-000005.txt   190213

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20220105.xsd EX-101.SCH 1927
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20220105_lab.xml EX-101.LAB 25250
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20220105_pre.xml EX-101.PRE 13159
7 EXTRACTED XBRL INSTANCE DOCUMENT isee-20220105_htm.xml XML 11433
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 22524470
SIC: 2834 Pharmaceutical Preparations